Security Snapshot

Immunocore Holdings plc - American Depository Shares, each representing one ordinary share, nominal value 0.002 euro per share (IMCR) Institutional Ownership

CUSIP: 45258D105

13F Institutional Holders and Ownership History from Q1 2021 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

136

Shares (Excl. Options)

52,107,219

Price

$31.75

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-402,881
Value change
-$5,978,380
Number of holders
136
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
51,428,571
SEC-reported price per share
$35.54
Insider filing price
$35.54
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • IMCR - Immunocore Holdings plc - American Depository Shares, each representing one ordinary share, nominal value 0.002 euro per share is tracked under CUSIP 45258D105.
  • 136 institutions reported positions in Q2 2026.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 142 to 136 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $1,579,585,800 to $1,653,707,855.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 136 institutions filings for Q2 2026.

Open SEC evidence

Security key

45258D105

Latest holder period

Q2 2026

13F holders

136

13D/G owners

8

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
8
Security
IMCR
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 12% +14% $190,355,150 +$26,410,388 5,959,773 +16% Wellington Management Group LLP 30 Jun 2026
Jallal Bahija 8.2% $135,513,072 4,493,139 Jallal Bahija 31 Dec 2024
FMR LLC 8.8% $137,573,437 4,307,246 FMR LLC 30 Jun 2026
PRIMECAP MANAGEMENT CO/CA/ 7.5% +44% $130,443,852 +$38,165,393 3,772,234 +41% PRIMECAP MANAGEMENT CO/CA/ 30 Jun 2025
Bellevue Group AG 5.6% $101,607,853 2,796,803 Bellevue Group AG 20 Aug 2025
TANG CAPITAL MANAGEMENT LLC 5.2% $94,662,520 2,605,608 TANG CAPITAL MANAGEMENT, LLC 17 Oct 2025
T. Rowe Price Investment Management, Inc. 3.7% -38% $60,417,704 -$36,740,710 1,891,600 -38% T. Rowe Price Investment Management, Inc. 31 Mar 2026
Vestal Point Capital, LP 3.5% -33% $57,492,000 -$30,881,764 1,800,000 -35% Vestal Point Capital, LP 30 Jun 2026

As of 30 Jun 2026, 136 institutional investors reported holding 52,107,219 shares of Immunocore Holdings plc - American Depository Shares, each representing one ordinary share, nominal value 0.002 euro per share (IMCR). This represents 101% of the company’s total 51,428,571 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
85%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
WELLINGTON MANAGEMENT GROUP LLP 11% 5,721,945 +22% 0.03% $181,671,753
RTW INVESTMENTS, LP 9.5% 4,869,798 0% 1.3% $154,616,087
FMR LLC 8.4% 4,307,246 -11% 0.01% $136,755,061
PRIMECAP MANAGEMENT CO/CA/ 7.1% 3,638,241 -1.5% 0.07% $115,514,154
Bellevue Group AG 5.4% 2,788,245 -0.31% 1.9% $88,526,779
TANG CAPITAL MANAGEMENT LLC 5.2% 2,649,368 0% 3.8% $84,117,434
Vestal Point Capital, LP 3.5% 1,800,000 -35% 1.3% $57,150,000
TWO SIGMA INVESTMENTS, LP 3.2% 1,648,983 +61% 0.04% $52,355,210
MILLENNIUM MANAGEMENT LLC 3.1% 1,597,037 +29% 0.03% $50,705,925
ARMISTICE CAPITAL, LLC 2.8% 1,428,000 +20% 1.3% $45,339,000
Caligan Partners LP 2.7% 1,381,317 2.1% $43,856,815
Kynam Capital Management, LP 2.7% 1,375,000 +55% 2.4% $43,656,250
BVF INC/IL 2.5% 1,294,463 0% 1.1% $41,099,200
ACADIAN ASSET MANAGEMENT LLC 2.4% 1,209,894 +141% 0.05% $38,391,000
Trails Edge Capital Partners, LP 2.1% 1,063,234 +56% 5.4% $33,757,680
BlackRock, Inc. 2% 1,004,598 +53% 0% $31,895,988
Point72 Asset Management, L.P. 1.9% 990,280 -10% 0.05% $31,441,390
PRICE T ROWE ASSOCIATES INC /MD/ 1.6% 831,068 -9.6% 0% $26,387,000
Jupiter Topco LLC 1.4% 709,022 0% 0.01% $22,504,358
Logos Global Management LP 1.2% 600,000 -60% 0.82% $19,050,000
MARSHALL WACE, LLP 1.1% 590,941 +228% 0.02% $18,762,377
Hudson Bay Capital Management LP 1.1% 590,000 -6.8% 0.09% $18,732,500
CITADEL ADVISORS LLC 1.1% 566,761 +146% 0.01% $17,994,662
BRAIDWELL LP 1% 521,327 0.61% $16,552,132
Jones Hill Capital LP 1% 512,856 3.5% $16,283,178

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
22
Latest
Q2 2026
Rows shown
1-22 of 22
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 52,107,219 $1,653,707,855 -$5,978,380 $31.75 136
2026 Q1 52,393,743 $1,579,585,800 +$22,621,289 $30.15 142
2025 Q4 51,535,356 $1,787,298,986 +$61,545,552 $34.71 149
2025 Q3 49,181,489 $1,786,701,511 +$50,897,730 $36.33 132
2025 Q2 47,759,431 $1,498,675,257 +$17,984,702 $31.38 132
2025 Q1 47,287,653 $1,402,998,400 +$60,274,148 $29.67 115
2024 Q4 45,410,647 $1,339,563,608 -$4,915,367 $29.50 114
2024 Q3 45,295,985 $1,411,075,539 +$61,107,953 $31.13 129
2024 Q2 43,068,701 $1,459,854,294 -$99,787,937 $33.89 135
2024 Q1 41,233,666 $2,679,814,816 +$238,809,048 $65.00 149
2023 Q4 37,514,062 $2,563,043,022 +$32,940,976 $68.32 133
2023 Q3 36,945,020 $1,917,423,501 +$85,494,203 $51.90 125
2023 Q2 35,306,138 $2,115,733,529 +$164,020,008 $59.96 118
2023 Q1 32,689,414 $1,614,615,481 +$118,700,415 $49.44 108
2022 Q4 30,264,419 $1,727,211,273 +$217,928,825 $57.07 103
2022 Q3 26,369,515 $1,237,624,033 +$261,557,875 $46.94 83
2022 Q2 21,039,614 $784,510,369 +$56,584,747 $37.31 66
2022 Q1 19,740,280 $590,138,252 +$57,754,634 $29.90 57
2021 Q4 17,133,052 $586,618,000 +$22,048,655 $34.24 45
2021 Q3 16,654,128 $617,381,000 +$83,084,443 $37.07 46
2021 Q2 13,805,464 $538,109,000 +$10,183,214 $39.05 41
2021 Q1 14,110,965 $597,836,000 +$597,835,003 $42.57 41
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .